CorMedix Inc (NASDAQ:CRMD)

3.10
Delayed Data
As of May 27
 -0.08 / -2.52%
Today’s Change
2.87
Today|||52-Week Range
8.38
-31.87%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$131.5M

Company Description

CorMedix, Inc. operates as a pharmaceutical and medical device company. The firm seeks to license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle in 2006 and is headquartered in Berkeley Heights, NJ.

Contact Information

CorMedix, Inc.
300 Connell Drive
Berkeley Heights New Jersey 07922
P:(908) 517-9500
Investor Relations:

Employees

Shareholders

Individual stakeholders3.76%
Other institutional22.23%
Mutual fund holders11.95%

Top Executives

Joseph TodiscoChief Executive Officer & Director
Mathew T. DavidChief Financial Officer & Executive Vice President
Antony E. PfaffleSecretary & Chief Scientific Officer
Elizabeth Masson-HurlburtExecutive VP-Clinical & Medical Affairs
Phoebe MountsEVP, General Counsel, Head-Regulatory & Compliance